Incidence and risk factors for cancer after liver transplantation

Critical Reviews in Oncology/Hematology

Volumn 56, Issue 1 SPEC. ISS., 2005, Pages 87-99

  Hernández Vallejo, Gonzalo ^a   Jiménez Romero, Carlos ^a,b   De Vicente, Juan Carlos ^c  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c University Hospital of Asturias   (Spain)

Author keywords

De novo tumors immunosuppression; De novo tumors liver transplantation; De novo tumors liver transplantation incidence; De novo tumors risk factors; Liver transplantation

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ALCOHOL CONSUMPTION; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; COLON CANCER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; KIDNEY CANCER; LIP CARCINOMA; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LUNG CANCER; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; OROPHARYNX CANCER; OROPHARYNX CARCINOMA; PRIMARY SCLEROSING CHOLANGITIS; PROGNOSIS; PROSTATE CANCER; REVIEW; RISK FACTOR; SKIN CARCINOMA; SKIN TUMOR; SMOKING; TOBACCO; UTERUS CANCER;

EID: 24644515392     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2004.12.011     Document Type: Review

References (102)

1. National Institutes of Health National Institutes of Health Consensus Development Conference Statement: liver transplantation Hepatology 4 1984 107 110
2. V.H. Karam, I. Gasquet, and V. Delvart Quality of life in adult survivors beyond 10 years after liver, kidney, and heart transplantation Transplantation 76 2003 1699 1704
3. P.A. Sheiner, J.F. Magliocca, and C.A. Bodian Long-term medical complications in patients surviving > or =5 years after liver transplant Transplantation 69 2000 781 789
4. J.J. Fung, A. Jain, E.J. Kwak, S. Kusne, I. Dvorchik, and B. Eghtesad De novo malignancies after liver transplantation: a major cause of late death Liver Transpl 7 2001 109 118
5. I. Penn The Changing Pattern of Posttransplant Malignancies Traspl Proc 23 1991 1101 1103
6. I. Penn, and Malignancy Surg Clin North Am 74 1994 1247 1257
7. I. Penn Posttransplant malignancies Transpl Proc 31 1999 1260 1262
8. I. Penn Cancers in renal transplant patients Adv Ren Replace Ther 7 2000 142 156
9. I. Penn Post-transplant malignancy: the role of immunosuppression Drug Saf 3 2000 101 103
10. S. Jonas, N. Rayes, and U. Neumann De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin Cancer 80 1997 1141 1150
11. E.E. Frezza, J.J. Fung, and D.H. van Thiel Non-lymphoid cancer after liver transplantation Hepatogastroenterology 44 1997 1172 1181
12. E.B. Haagsma, V.E. Hagens, and M. Schaapveld Increased cancer risk after liver transplantation: a population-based study J Hepatol 34 2001 84 91
13. D.M. Kelly, E. Sukru, R.G. Stephen, C.M. Miller, M.E. Schwartz, and P.A. Sheiner Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors Cancer 83 1998 1237 1243
14. M. Berenguer, M. Prieto, and M. Bustamante Incidence of de novo neoplasms after liver transplantation Med Clin 111 1998 481 484
15. V. Peyrègne, C. Ducerf, and M. Admam De novo cancer after orthotopic liver transplantation Tranpl Proc 30 1998 1484 1485
16. M. Levy, L. Backman, and B. Husberg De novo malignancy following liver transplantation: a single center study Transpl Proc 25 1993 1397 1399
17. A.B. Jain, L.D. Yee, and M.A. Nalesnik Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data Transplantation 66 1998 1193 1200
18. E. Rubio, J.M. Moreno, V.S. Turrión, M. Jiménez, J.L. Lucena, and V. Cuervas-Mons De novo malignancies and liver transplantation Transpl Proc 35 2003 1896 1897
19. S. Saigal, S. Norris, P. Muiesan, M. Rela, N. Heaton, and J. O'Grady Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation Liver Transpl 8 2002 482 487
20. E.Q. Sánchez, S. Marubashi, and G. Jung De novo tumors after liver transplantation: a single-institution experience Liver Transpl 8 2002 285 291
21. X. Xiol, J. Guardiola, and S. Menéndez Risk factors for development of de novo neoplasia after liver transplantation Liver Transpl 7 2001 971 975
22. S. Benlloch, M. Berenguer, and M. Prieto De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years? Am J Transpl 4 2004 596 604
23. J. Briceño, P. López-Cillero, E. Fraga, and C. Pera Results of liver transplantation in a Spanish group: a report from the Cordoba unit Clin Transpl 2001 187 194
24. E. Jaurrieta, L. Casais, and J. Figueras Analysis of 500 liver transplantations at Bellvitge Hospital Med Clin 115 2000 521 529
25. C.O. Bellamy, A.M. DiMartini, and K. Ruppert Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence Transplantation 72 2001 619 626
26. C. Jiménez, D. Rodríguez, and E. Marqués De novo tumors after orthotopic liver transplantation Transpl Proc 34 2002 297 298
27. X. Bessa, H. Andreu, and I. Cirera De novo tumors in adult patients with hepatic transplant Gastroenterol Hepatol 20 1997 442 445
28. J.M. Valero, E. Rubio, J.M. Moreno, F. Pons, V. Sánchez- Turrión, and V. Cuevas-Mons De novo malignancies in liver transplantation Transpl Proc 35 2003 709 711
29. M.V. Catalina, A. de Diego, and A. García-Sánchez Characterization of de novo malignancies in liver transplantation Gastroenterol Hepatol 26 2003 57 63
30. H. Schmilovitz-Weiss, E. Mor, and J. Sulkes De novo tumors after liver transplantation: a single-center experience Transpl Proc 35 2003 665 666
31. R. Safadi, Y. Ilan, and A. Eid Solid Tumors after liver transplantation Transpl Proc 31 1999 1894 1895
32. A. España, P. Redondo, and A.L. Fernández Skin cancer in heart transplant patients J Am Acad Dermatol 32 1995 458 465
33. I. Penn The problem of cancer in organ transplant recipients Transpl Sci 4 1994 23 32
34. U. Frei, U. Bode, and H. Repp Malignancies under cyclosporine after kidney transplantation: analysis of a ten years period Transpl Proc 25 1993 1394
35. S. Saigal, S. Norris, and P. Srinivasan Successful outcome of orthotopic liver transplantation in patients with preexisting malignant states Liver Tranpl 7 2001 11 15
36. J.I. Herrero, J.F. Lucena, and J. Quiroga Liver transplant recipients older than 60 years have lower survival and higher incidence of malignancy Am J Transpl 3 2003 1407 1412
37. I. Penn Posttransplantation de novo tumors in liver allograft recipients Liver Transpl Surg 2 1996 52 59
38. M.R. First, and V.R. Peddi Malignancies complicating organ transplantation Transpl Proc 30 1998 2768 2770
39. S. Gruber, and A.G. Matas Etiology and pathogenesis of tumors occurring after organ transplantation Transpl Sci 4 1994 87 104
40. I. Penn Cancer in the immunosuppressed organ recipient Transpl Proc 23 1991 1771 1772
41. M.A. Nalesnik, A.J. Demetris, J.J. Fung, and T.E. Starzl Lymphoproliferative disorders arising under immunosuppression with FK506: initial observations in a large transplant population Transpl Proc 23 1991 1108 1110
42. J. Dantal, M. Hourmant, and D. Cantarovitch Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens Lancet 351 1998 623 628
43. N.M. Kneteman, J. Oberholzer, and M. Al Saghier Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma Liver Transpl 10 2004 1301 1311
44. G.E. Koehl, G.E. Koehl, and J. Andrassy Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice Transplantation 77 2004 1319 1326
45. J.M. Campistol, A. Gutierrez-Dalmau, and J.V. Torregrosa Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma Transplantation 77 2004 760 762
46. S.A. Birkeland, H.K. Andersen, and S.J. Hamilton-Dutoit Preventing acute rejection, Epstein-Barr virus infection, and posttransplant lymphoproliferative disorders after kidney transplantation: use of aciclovir and mycophenolate mofetil in a steroid-free immunosuppressive protocol Transplantation 67 1999 1209 1214
47. S.A. Birkeland, and S. Hamilton-Dutoit Is posttransplant lymphoproliferative disorder caused by any specific immunosuppressive drug or by the transplantation per se? Transplantation 76 2003 984 988
48. G. Hernández, L. Arriba, and C. Jiménez Rapid progression from oral leukoplakia to carcinoma in an immunosuppressed liver transplant recipient Oral Oncol 39 2003 87 90
49. G.N. King, C.M. Healy, and M.T. Glover Increase prevalence of dysplastic and malignant lip lesions in renal transplant recipients N Engl J Med 332 1995 1052 1057
50. G.N. King, C.M. Healy, and M.T. Glover Prevalence and risk factors associated with leukoplakia, hairy leukoplakia, erythematous candidiasis, and gingival hyperplasia in renal recipients Oral Surg Oral Med Oral Pathol 78 1994 718 726
51. J.F. Trotter, and S.R. Brazer Rapid progression to high-grade dysplasia in Barrett's esophagus after liver transplantation Liver Transpl Surg 5 1999 332 333
52. A.M. Wolke, F. Schaffner, B. Kapelman, and H.S. Sacks Malignancy in primary biliary cirrhosis. High incidence of breast cancer in affected women Am J Med 76 1984 1075 1078
53. S. Jonas, W.O. Bechstein, and N. Rayes Posttransplant malignancy and newer immunosuppressive protocols after liver transplantation Transpl Proc 28 1996 3246 3247
54. C. Duvoux, I. Delacroix, and J.P. Richardet Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation Transplantation 67 1999 418 421
55. G. Jiménez, E. Marques, and C. Loinaz Upper aerodigestive tract and lung tumors after liver transplantation Transpl Proc 35 2003 1900 1901
56. G. Roselle, C.L. Mendenhall, and C.J. Grossman Effects of alcohol on immunity and cancer R. Yirmiya AN. Taylor Alcohol, immunity and cancer 1993 CRC Boca Raton, FL 3 21
57. D.W. Hanto, K.J. Gajl-Peczalska, and G. Frizzera Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative disease occurring after renal transplantation Ann Surg 198 1983 356 369
58. J.I. Cohen Epstein-Barr virus infection N Engl J Med 343 2000 481 492
59. C. Paya, J.J. Fung, and M.A. Nalesnik Epstein-Barr virus-induced posttransplant lymphoproliferative disorders Transplantation 68 1999 1517 1525
60. A.G.R. Sheil, A.P.S. Disney, T.H. Mathew, V.E.R. Livingston, and A.M. Keogh Lymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantation Transpl Proc 29 1997 825 827
61. A. Gonzalez-Chamorro, C. Jiménez, and E. Moreno Management and outcome of liver recipients with post-transplant lymphoproliferative disease Hepatogastroenterology 47 2000 211 219
62. C. Duvoux, G.P. Pageux, and C. Vanlemmes Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients Transplantation 74 2002 1103 1109
63. A. Jain, J. Reyes, and R. Kahhyap Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients Transpl Proc 30 1998 1403 1404
64. T.V. Cacciarelli, M. Green, and R. Jaffe Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy Transplantation 66 1998 1047 1052
65. M. Green, T.V. Cacciarelli, and G. Mazariegos Serial measurements of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease Transplantation 66 1998 1641 1644
66. P.R. Beatty, S.M. Krams, C.O. Esquivel, and O.M. Martínez Effect of cyclosporine and tacrolimus on the growth of Epstein-Barr virus-transformed B-cell lines Transplantation 65 1998 1248 1255
67. M. Hojo, T. Morimoto, and M. Maluccio Cyclosporine induces cancer progression by a cell-autonomous mechanism Nature 397 1999 530 534
68. E.M. Sokal, T. Caragiozoglou, M. Lamy, R. Reding, and J.B. Otte Epstein-Barr virus serology and Epstein-Barr virus-associated lymphoproliferative disorders in pediatric liver transplant recipients Transplantation 56 1993 1394 1398
69. K.L. Cox, L.S. Lawrence-Miyasaki, and R. García-Kennedy An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation Transplantation 59 1995 524 529
70. A. Jain, G. Mazariegos, and R. Kashyap Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation Transplantation 70 2000 617 627
71. K. McLaughlin, S. Wajstaub, and P. Marotta Increased risk for posttransplant lymphoproliferative disease in recipients of liver transplants with hepatitis C Liver Transpl 6 2000 570 574
72. A.B. Mithoefer, S. Supran, and R.B. Freeman Risk factors associated with the development of skin cancer after liver transplantation Liver Transpl 8 2002 939 944
73. C.A. Harwood, J.M. McGregor, and V.J. Swale High frequency and diversity of cutaneous appendageal tumors in organ transplant recipients J Am Acad Dermatol 48 2003 401 408
74. J.J. Wu, and I.F. Orengo Squamous cell carcinoma in solid-organ transplantation Dermatol Online J 8 2002 4
75. C.C. Otley, and M.R. Pittelkow Skin cancer in liver transplant recipients Liver Transpl 6 2000 253 262
76. J.N. Bouwes Bavinck, B.J. Vermeer, and F.J. van der Woude Relation between skin cancer and HLA antigens in renal-transplant recipients N Engl J Med 325 1991 843 848
77. J.N. Bouwes Bavinck, D.R. Hardie, and A. Green The risk of skin cancer in renal transplant recipients in Queensland, Australia Transplantation 61 1996 715 721
78. C.C. Otley, B.M. Coldiron, T. Stasko, and G.D. Goldman Decreased skin cancer after cessation of therapy with transplant associated immunosuppressant Arch Dermatol 137 2001 459 463
79. D. Salard, N. Parriaux, and C. Derancourt Cutaneous complications following liver transplantation: epidemiologic and clinical study in 86 patients Ann Dermatol Venereol 129 2002 1134 1138
80. J.H. Siegel, R. Janis, J.C. Alper, H. Schutte, L. Robbins, and M.D. Blaufox Disseminated visceral Kaposi's sarcoma. Appearance after human renal homograft operation JAMA 207 1969 1493 1496
81. F. Colina, F. López-Ríos, C. Lumbreras, J. Martínez-Laso, I. García García, and E. Moreno-Gonzalez Kaposi's sarcoma developing in a liver graft Transplantation 61 1996 1779 1781
82. P. Aseni, M. Vertemati, and E. Minola Kaposi's sarcoma in liver transplant recipients: morphological and clinical description Liver Transpl 7 2001 816 823
83. D. Farge Kaposi's sarcoma in organ transplant recipients. The Collaborative transplantation research group of ile de France Eur J Med 6 1993 339 343
84. H. Bismuth, D. Samuel, P.Y. Venancie, G. Menouar, and A.M. Szekely Development of Kaposi's sarcoma in liver transplant recipients: characteristics, management, and outcome Transpl Proc 23 1991 1438 1439
85. M. Andreoni, D. Goletti, and P. Pezzotti Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients J Infect 43 2001 195 199
86. V. Besnard, S. Euvrard, and J. Kanitakis Kaposi's sarcoma after liver transplantation Dermatology 193 1996 100 104
87. G. Cathomas, M. Tamm, and C.E. McGandy Transplantation associated malignancies: restriction of human herpes virus 8 to Kaposi's sarcoma Transplantation 64 1997 175 178
88. L.P. Jacobson, and H.K. Armenian An integrated approach to the epidemiology of Kaposi's sarcoma Curr Opin Oncol 7 1995 450 455
89. M.L. Galve, V. Cuervas-Mons, and J. Figueras Incidence and outcome of de novo malignancies after liver transplantation Transpl Proc 31 1999 1275 1277
90. T.A. Brentnall, R.C. Haggitt, and P.S. Rabinovitch Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis Gastroenterology 110 1996 331 338
91. A. Vera, B.K. Gunson, and V. Ussatoff Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis Transplantation 75 2003 1983 1988
92. H. Higashi, K. Yanaga, J.W. Marsh, A. Tzakis, S. Kakizoe, and T.E. Starzl Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis Hepatology 11 1990 477 480
93. K.L. Carson, and C.M. Hunt Medical problems occurring after orthotopic liver transplantation Dig Dis Sci 42 1997 1666 1674
94. R. Fabia, M.F. Levy, and G. Testa Colon carcinoma in patients undergoing liver transplantation Am J Surg 176 1998 265 269
95. W. van de Vrie, R.A. de Man, H.R. Van Buuren, W.R. Schouten, H.W. Tilanus, and H.J. Metselaar Inflammatory bowel disease and liver transplantation for primary sclerosing cholangitis Eur J Gastroenterol Hepatol 15 2003 657 663
96. R. Bleday, E. Lee, J. Jessurum, J. Heine, and W.D. Wong Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease Dis Colon Rectum 36 1993 908 912
97. G.V. Papatheodoridis, M. Hamilton, P.K. Mistry, B. Davidson, K. Rolles, and A.K. Burroughs Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis Gut 43 1998 639 644
98. I. Dvorchik, M. Subotin, and A.J. Demetris Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis Hepatology 35 2002 380 384
99. A. Jain, A. DiMartini, R. Kashyap, A. Youk, S. Rohal, and J. Fung Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus Transplantation 15 2000 1335 1342
100. G.P. Pageaux, J. Michel, and V. Coste Alcoholic cirrhosis is a good indication for liver transplantation, even for cases of recidivism Gut 45 1999 421 426
101. S. Meng, and L. Jiamei Management of tongue cancer in the patient who is systemically immunosuppressed: a preliminary report Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90 2000 689 693
102. C. Duvoux, D. Cherqui, and J. Delacroix Upper respiratory and digestive tract malignancies after liver transplantation for alcoholic cirrhosis Transpl Proc 28 1996 2883